O' Reilly P, Beatty S
Department of Ophthalmology, Waterford Regional Hospital, Waterford, Republic of Ireland.
Eye (Lond). 2007 Apr;21(4):518-21. doi: 10.1038/sj.eye.6702255. Epub 2006 Jan 27.
We report the operative details and surgical outcomes of 39 consecutive transconjunctival sutureless vitrectomies using the TSV 25 system.
We retrospectively reviewed the medical records of 35 patients (39 eyes) who underwent surgery using TSV 25 at the Department of Ophthalmology, Waterford Regional Hospital between March 2003 and February 2005. Preoperative, intraoperative and postoperative details were recorded and analysed. We also performed a systematic review of our surgical technique.
Mean (+/-SD; range) duration of surgery was 32.85 (17.54; 5-85) min. Methods of anaesthesia included retrobulbar anaesthesia (31; 79.5%) and general anaesthesia (8; 20.5%). The mean (+/-SD; range) length of stay was 1.53 (1.25; 0-4) days. Mean (+/-SD; range) visual acuities (logMAR) were -1.335 (1.15; 0.0 to -3.0) and -0.803 (1.03; 0.1 to -3.0) preoperatively and postoperatively, respectively. The mean (+/-SD) intraocular pressures were 14.69 (4.64) mmHg and 11.56 (9.03) mmHg preoperatively and at the first dressing, respectively. Intraoperative complications included blockage of the TSV cutter tip during attempted clearance of organized intragel haemorrhage, thus requiring conversion to conventional trans pars plana vitrectomy (1; 2.6%). No other intraoperative complication arose. Complications in the postoperative period included: reactivation of dormant chorioretinal toxoplasmosis (1; 2.6%); postoperative posterior segment haemorrhage (3; 7.7%); hyphaema (1; 2.6%); transient postoperative hypotony (10; 25.6%).
With appropriate case selection, and with appreciation of this technique's limitations, transconjunctival sutureless vitrectomy is a safe procedure.
我们报告连续39例使用TSV 25系统进行经结膜无缝线玻璃体切除术的手术细节及手术结果。
我们回顾性分析了2003年3月至2005年2月在沃特福德地区医院眼科接受TSV 25手术的35例患者(39只眼)的病历。记录并分析术前、术中和术后的详细情况。我们还对手术技术进行了系统回顾。
手术平均(±标准差;范围)时长为32.85(17.54;5 - 85)分钟。麻醉方法包括球后麻醉(31例;79.5%)和全身麻醉(8例;20.5%)。平均(±标准差;范围)住院时间为1.53(1.25;0 - 4)天。术前和术后平均(±标准差;范围)视力(logMAR)分别为-1.335(1.15;0.0至-3.0)和-0.803(1.03;0.1至-3.0)。术前和首次换药时平均(±标准差)眼压分别为14.69(4.64)mmHg和11.56(9.03)mmHg。术中并发症包括在试图清除机化性玻璃体内出血时TSV切割头堵塞,因此需要转为传统经睫状体平坦部玻璃体切除术(1例;2.6%)。未出现其他术中并发症。术后并发症包括:潜伏性脉络膜视网膜弓形虫病复发(1例;2.6%);术后眼后段出血(3例;7.7%);前房积血(1例;2.6%);术后短暂性低眼压(10例;25.6%)。
通过适当的病例选择,并认识到该技术的局限性,经结膜无缝线玻璃体切除术是一种安全的手术。